Vitro Biopharma, Inc.
SEC CIK 793171 · sf7iz$rp · last insider filing 2023-06-30
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Furman Christopher | Director · Chief Executive Officer | filed 2022 - 2023 |
| Zamora Jack | Director | filed 2022 - 2022 |
| Musick James R | Director · President/CEO | filed 2006 - 2022 |
| James R Musick Trust | Director · Pres / CEO | filed 2006 - 2022 |
| Packs John | Director | filed 2022 - 2022 |
| Mosessian Caroline | Director · Chair of the Board, CRO | filed 2022 - 2022 |
| Evans John | Director · CFO | filed 2017 - 2017 |
| Shuster Pete | Director | filed 2014 - 2014 |
| Liter Jeffrey Scott | Director | filed 2014 - 2014 |
| VAN Horn Erik | Director | filed 2009 - 2011 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Haas Nathan | Chief Financial Officer | filed 2022 - 2022 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.